Two clues make a proof: EUS-directed transgastric ERCP in twice-surgically altered anatomy—Roux-en-Y gastric bypass conversion of a sleeve gastrectomy


Bone loss, deterioration persist 5 years after gastric bypass


Adults with obesity who underwent Roux-en-Y gastric bypass experienced high-turnover bone loss and bone microarchitectural deterioration that persisted 5 years after the procedure, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

“[Roux-en-Y gastric bypass]-associated skeletal fragility is mediated by accelerated, high-turnover bone loss and has been documented in the short term in multiple longitudinal studies,” Katherine G. Lindeman, of the endocrine unit at Massachusetts General Hospital, Boston, and colleagues wrote in the study background. “Collectively, these studies document that a decline in bone density up to 10% is common in the initial 1-2 years after [Roux-en-Y gastric bypass]. [Roux-en-Y gastric bypass] also leads to short-term declines in volumetric bone density of the axial and peripheral skeleton and weakening of peripheral bone microarchitecture. However, the long-term skeletal consequences of [Roux-en-Y gastric bypass] have not been well-characterized beyond these initial postsurgical years.”

In an observational study, researchers assessed longitudinal data on 21 patients with obesity undergoing Roux-en-Y gastric bypass at an academic medical center.

DXA was used to measure spine and hip areal bone mineral density, and quantitative CT was used to measure trabecular volumetric BMD of the spine. In a subset of participants, high-resolution peripheral quantitative CT was used to measure volumetric BMD and microarchitecture of the distal radius and tibia.

At each study visit, the researchers also measured serum type 1 collagen C-terminal telopeptide (CTX), which assesses bone resorption, and procollagen type 1 N-terminal propeptide (P1NP), which evaluates bone formation, and assessed physical activity. Study participants were advised to maintain a calcium intake between 1,200 mg and 1,500 mg daily and a vitamin D intake of 3,000 IU daily throughout the study.

At 5 years, researchers observed a mean 7.8% decrease in areal BMD at the spine and a mean 15.3% decrease in areal BMD at the total hip. However, the pace of spine areal BMD reduction slowed over time, with most of the bone loss observed within the first 2 years, according to researchers.

At the femoral neck, areal BMD decreased by a mean of 14.1% at 5 years. Additionally, researchers observed a mean 12.1% decrease in trabecular spine volumetric BMD at 5 years (P .001).

Peripheral sites showed continued and stable decreases over 5 years, with parallel reductions in cortical and trabecular microarchitecture. This led to a 20% decrease in estimated failure load at the radius and a 13% decrease at the tibia (P < .001), the researchers wrote.

After Roux-en-Y gastric bypass, significant increases in bone turnover markers were seen. At 2 years postoperatively, serum CTX was 196% higher vs. baseline levels and remained 150% above baseline at 5 years (P < .001). Increases were also seen in serum P1NP, reaching the highest point at 63% at 3.5 years after surgery, and remaining 34% higher at 5 years (P = .017 for comparisons vs. baseline).

“We found that areal and volumetric bone density and skeletal microarchitecture continue to deteriorate through 5 years after [Roux-en-Y gastric bypass] surgery, leading to substantial, cumulative bone loss,” the researchers wrote. “Adults undergoing [Roux-en-Y gastric bypass] warrant close follow-up to detect changes in bone density as well as to prevent secondary hyperparathyroidism and promote physical activity.” – by Jennifer Byrne

Roux-en-Y gastric bypass may be superior to gastric banding for weight loss, correction of comorbidities among morbidly obese.


Compared with gastric banding, roux-en-Y gastric bypass was associated with improved weight loss and superior correction of some comorbidities among morbidly obese patients. The early complication rate was higher for bypass, but researchers said this is compensated largely by the higher, long-term complication and reoperation rates seen with gastric banding.

“The prevalence of morbid obesity has been growing exponentially over the past 20 years,” Michel Suter, MD, of the Department of Surgery at Hospital du Chablais, Aigle-Monthey in Switzerland, and colleagues wrote. “A recent survey showed that bariatric procedures have more than doubled between 2003 and 2008. In the United States, the increase was much greater for gastric banding than for gastric bypass.”

Despite gastric banding’s popularity, the researchers hypothesized that roux-en-Y gastric bypass provides superior results. To test their hypothesis, they performed a matched-pair study of 442 patients with a BMI of less than 50. Patients were matched based on age, sex and BMI, and interventions included laparoscopic gastric banding or roux-en-Y gastric bypass. The primary outcomes were operative morbidity, weight loss, residual BMI, quality of life, food tolerance, lipid profile and long-term morbidity.

Follow-up was 92.3% 6 years after surgery. Significantly more early complications occurred after roux-en-Y gastric bypass (17.2%) vs. gastric banding (5.4%; P< .001). However, most were not life-threatening and were treated conservatively, the researchers wrote.

Maximal weight loss occurred after a mean 36 months in the banding group vs. 18 months in the gastric bypass group (P< .01). Additionally, in the bypass group, maximal excess weight loss was significantly higher (78.5% vs. 64.8%; P< .001), and the mean nadir BMI was lower (26.7 vs. 29.4; P< .001).

More failures � defined as a BMI of more than 35 or reversal of procedure/conversion � occurred in the banding group at 6 years vs. bypass (48.3% vs. 12.3%; P< .001). In addition, compared with bypass surgery, banding was associated with more long-term complications (19% vs. 41.6%; P< .001) and more reoperations (12.7% vs. 26.7%; P< .001).

According to Jacques Himpens, MD, of the European School of Laparoscopy at Saint Pierre University Hospital in Brussels, Belgium, and author of an accompanying editorial, roux-en-Y gastric bypass is a better bariatric procedure compared with gastric banding, but caveats remain.

Among these, Himpens said, “A well-performed gastric banding is better than a poorly executed roux-en-Y gastric bypass,” and the limited influence gastric banding has on incretins and other gastrointestinal hormones could be advantageous in the long-term.

“Notwithstanding these words of caution, Suter et al must be commended for their scientific rigor and zealous follow-up,” he wrote. “Both constitute an enlightening example for all of us bariatric surgeons.”

Source:Endocrine Today